Found 72 hits Enz. Inhib. hit(s) with all data for entry = 50014907 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148952
(CHEMBL429152 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)c2cccc(Oc3ccccc3)c2)cc1 Show InChI InChI=1S/C31H30N6O4/c1-20(35-28(38)19-34-31(40)37-25-16-12-22(13-17-25)29(32)33)21-10-14-24(15-11-21)36-30(39)23-6-5-9-27(18-23)41-26-7-3-2-4-8-26/h2-18,20H,19H2,1H3,(H3,32,33)(H,35,38)(H,36,39)(H2,34,37,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148947
(CHEMBL339880 | Piperidine-4-carboxylic acid [4-(1-...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)C2CCNCC2)cc1 Show InChI InChI=1S/C24H31N7O3/c1-15(16-2-6-19(7-3-16)30-23(33)18-10-12-27-13-11-18)29-21(32)14-28-24(34)31-20-8-4-17(5-9-20)22(25)26/h2-9,15,18,27H,10-14H2,1H3,(H3,25,26)(H,29,32)(H,30,33)(H2,28,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148950
(CHEMBL332753 | N-[1-(3-Bromo-4-morpholin-4-yl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(N2CCOCC2)c(Br)c1 Show InChI InChI=1S/C22H27BrN6O3/c1-14(16-4-7-19(18(23)12-16)29-8-10-32-11-9-29)27-20(30)13-26-22(31)28-17-5-2-15(3-6-17)21(24)25/h2-7,12,14H,8-11,13H2,1H3,(H3,24,25)(H,27,30)(H2,26,28,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148953
(4-(1-{2-[3-(4-Carbamimidoyl-phenyl)-ureido]-acetyl...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(cc1)C(=O)Nc1ccccc1 Show InChI InChI=1S/C25H26N6O3/c1-16(17-7-9-19(10-8-17)24(33)30-20-5-3-2-4-6-20)29-22(32)15-28-25(34)31-21-13-11-18(12-14-21)23(26)27/h2-14,16H,15H2,1H3,(H3,26,27)(H,29,32)(H,30,33)(H2,28,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148945
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-m...)Show SMILES COc1cccc(COc2ccc(cc2)C(C)NC(=O)CNC(=O)Nc2ccc(cc2)C(N)=N)c1 Show InChI InChI=1S/C26H29N5O4/c1-17(19-8-12-22(13-9-19)35-16-18-4-3-5-23(14-18)34-2)30-24(32)15-29-26(33)31-21-10-6-20(7-11-21)25(27)28/h3-14,17H,15-16H2,1-2H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148958
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-c...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(OCc2cccc(Cl)c2)cc1 Show InChI InChI=1S/C25H26ClN5O3/c1-16(18-7-11-22(12-8-18)34-15-17-3-2-4-20(26)13-17)30-23(32)14-29-25(33)31-21-9-5-19(6-10-21)24(27)28/h2-13,16H,14-15H2,1H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148949
(CHEMBL339200 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)c2cccc(C)c2)cc1 Show InChI InChI=1S/C26H28N6O3/c1-16-4-3-5-20(14-16)25(34)31-21-10-6-18(7-11-21)17(2)30-23(33)15-29-26(35)32-22-12-8-19(9-13-22)24(27)28/h3-14,17H,15H2,1-2H3,(H3,27,28)(H,30,33)(H,31,34)(H2,29,32,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148960
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-nap...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc2ccccc2c1 Show InChI InChI=1S/C22H23N5O2/c1-14(17-7-6-15-4-2-3-5-18(15)12-17)26-20(28)13-25-22(29)27-19-10-8-16(9-11-19)21(23)24/h2-12,14H,13H2,1H3,(H3,23,24)(H,26,28)(H2,25,27,29)/t14-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50126571
(CHEMBL35586 | N-[(S)-1-(3-Bromo-phenyl)-ethyl]-2-[...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1cccc(Br)c1 Show InChI InChI=1S/C18H20BrN5O2/c1-11(13-3-2-4-14(19)9-13)23-16(25)10-22-18(26)24-15-7-5-12(6-8-15)17(20)21/h2-9,11H,10H2,1H3,(H3,20,21)(H,23,25)(H2,22,24,26)/t11-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148954
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-morp...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(N2CCOCC2)c(c1)C(F)(F)F Show InChI InChI=1S/C23H27F3N6O3/c1-14(16-4-7-19(18(12-16)23(24,25)26)32-8-10-35-11-9-32)30-20(33)13-29-22(34)31-17-5-2-15(3-6-17)21(27)28/h2-7,12,14H,8-11,13H2,1H3,(H3,27,28)(H,30,33)(H2,29,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148961
(2-Benzyloxy-5-(1-{2-[3-(4-carbamimidoyl-phenyl)-ur...)Show SMILES COC(=O)c1cc(ccc1OCc1ccccc1)C(C)NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N Show InChI InChI=1S/C27H29N5O5/c1-17(31-24(33)15-30-27(35)32-21-11-8-19(9-12-21)25(28)29)20-10-13-23(22(14-20)26(34)36-2)37-16-18-6-4-3-5-7-18/h3-14,17H,15-16H2,1-2H3,(H3,28,29)(H,31,33)(H2,30,32,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148951
(CHEMBL330943 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)c2ccccc2)cc1 Show InChI InChI=1S/C25H26N6O3/c1-16(17-7-11-20(12-8-17)30-24(33)19-5-3-2-4-6-19)29-22(32)15-28-25(34)31-21-13-9-18(10-14-21)23(26)27/h2-14,16H,15H2,1H3,(H3,26,27)(H,29,32)(H,30,33)(H2,28,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 34 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50126579
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[(S)-1-(3-...)Show SMILES COc1cccc(c1)[C@H](C)NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N Show InChI InChI=1S/C19H23N5O3/c1-12(14-4-3-5-16(10-14)27-2)23-17(25)11-22-19(26)24-15-8-6-13(7-9-15)18(20)21/h3-10,12H,11H2,1-2H3,(H3,20,21)(H,23,25)(H2,22,24,26)/t12-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 35 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148946
(4-(1-{2-[3-(4-Carbamimidoyl-phenyl)-ureido]-acetyl...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(cc1)C(=O)Nc1cccc(Oc2ccccc2)c1 Show InChI InChI=1S/C31H30N6O4/c1-20(35-28(38)19-34-31(40)37-24-16-14-22(15-17-24)29(32)33)21-10-12-23(13-11-21)30(39)36-25-6-5-9-27(18-25)41-26-7-3-2-4-8-26/h2-18,20H,19H2,1H3,(H3,32,33)(H,35,38)(H,36,39)(H2,34,37,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 43 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148956
(CHEMBL123336 | Cyclopropanecarboxylic acid [4-(1-{...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)C2CC2)cc1 Show InChI InChI=1S/C22H26N6O3/c1-13(14-4-8-17(9-5-14)27-21(30)16-2-3-16)26-19(29)12-25-22(31)28-18-10-6-15(7-11-18)20(23)24/h4-11,13,16H,2-3,12H2,1H3,(H3,23,24)(H,26,29)(H,27,30)(H2,25,28,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148966
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(3,4-di...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Cl)c(Cl)c1 Show InChI InChI=1S/C18H19Cl2N5O2/c1-10(12-4-7-14(19)15(20)8-12)24-16(26)9-23-18(27)25-13-5-2-11(3-6-13)17(21)22/h2-8,10H,9H2,1H3,(H3,21,22)(H,24,26)(H2,23,25,27) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148959
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Oc2ccccc2)cc1 Show InChI InChI=1S/C24H25N5O3/c1-16(17-9-13-21(14-10-17)32-20-5-3-2-4-6-20)28-22(30)15-27-24(31)29-19-11-7-18(8-12-19)23(25)26/h2-14,16H,15H2,1H3,(H3,25,26)(H,28,30)(H2,27,29,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 78 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148944
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(4-m...)Show SMILES COc1ccc(Oc2ccc(cc2)C(C)NC(=O)CNC(=O)Nc2ccc(cc2)C(N)=N)cc1 Show InChI InChI=1S/C25H27N5O4/c1-16(17-5-9-21(10-6-17)34-22-13-11-20(33-2)12-14-22)29-23(31)15-28-25(32)30-19-7-3-18(4-8-19)24(26)27/h3-14,16H,15H2,1-2H3,(H3,26,27)(H,29,31)(H2,28,30,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148964
(CHEMBL121981 | N-[1-(4-Benzyloxy-phenyl)-ethyl]-2-...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(OCc2ccccc2)cc1 Show InChI InChI=1S/C25H27N5O3/c1-17(19-9-13-22(14-10-19)33-16-18-5-3-2-4-6-18)29-23(31)15-28-25(32)30-21-11-7-20(8-12-21)24(26)27/h2-14,17H,15-16H2,1H3,(H3,26,27)(H,29,31)(H2,28,30,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 133 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148955
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-morp...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(cc1)N1CCOCC1 Show InChI InChI=1S/C22H28N6O3/c1-15(16-4-8-19(9-5-16)28-10-12-31-13-11-28)26-20(29)14-25-22(30)27-18-6-2-17(3-7-18)21(23)24/h2-9,15H,10-14H2,1H3,(H3,23,24)(H,26,29)(H2,25,27,30) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 142 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148957
(CHEMBL122765 | N-[1-((S)-4-Bromo-phenyl)-ethyl]-2-...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Br)cc1 Show InChI InChI=1S/C18H20BrN5O2/c1-11(12-2-6-14(19)7-3-12)23-16(25)10-22-18(26)24-15-8-4-13(5-9-15)17(20)21/h2-9,11H,10H2,1H3,(H3,20,21)(H,23,25)(H2,22,24,26)/t11-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 156 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148965
(CHEMBL122151 | N-[1-(4-Benzyl-phenyl)-ethyl]-2-[3-...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Cc2ccccc2)cc1 Show InChI InChI=1S/C25H27N5O2/c1-17(20-9-7-19(8-10-20)15-18-5-3-2-4-6-18)29-23(31)16-28-25(32)30-22-13-11-21(12-14-22)24(26)27/h2-14,17H,15-16H2,1H3,(H3,26,27)(H,29,31)(H2,28,30,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 190 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148948
(CHEMBL122863 | N-[1-(4-Acetylamino-phenyl)-ethyl]-...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(C)=O)cc1 Show InChI InChI=1S/C20H24N6O3/c1-12(14-3-7-16(8-4-14)25-13(2)27)24-18(28)11-23-20(29)26-17-9-5-15(6-10-17)19(21)22/h3-10,12H,11H2,1-2H3,(H3,21,22)(H,24,28)(H,25,27)(H2,23,26,29) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 196 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148943
(CHEMBL338641 | N-[1-(3-Benzyloxy-phenyl)-1-methyl-...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1cccc(OCc2ccccc2)c1 Show InChI InChI=1S/C25H27N5O3/c1-17(20-8-5-9-22(14-20)33-16-18-6-3-2-4-7-18)29-23(31)15-28-25(32)30-21-12-10-19(11-13-21)24(26)27/h2-14,17H,15-16H2,1H3,(H3,26,27)(H,29,31)(H2,28,30,32) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 256 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50126585
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-phe...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccccc1 Show InChI InChI=1S/C18H21N5O2/c1-12(13-5-3-2-4-6-13)22-16(24)11-21-18(25)23-15-9-7-14(8-10-15)17(19)20/h2-10,12H,11H2,1H3,(H3,19,20)(H,22,24)(H2,21,23,25)/t12-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 430 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148963
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(2,4...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Oc2ccc(Cl)cc2Cl)cc1 Show InChI InChI=1S/C24H23Cl2N5O3/c1-14(15-4-9-19(10-5-15)34-21-11-6-17(25)12-20(21)26)30-22(32)13-29-24(33)31-18-7-2-16(3-8-18)23(27)28/h2-12,14H,13H2,1H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 483 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148961
(2-Benzyloxy-5-(1-{2-[3-(4-carbamimidoyl-phenyl)-ur...)Show SMILES COC(=O)c1cc(ccc1OCc1ccccc1)C(C)NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N Show InChI InChI=1S/C27H29N5O5/c1-17(31-24(33)15-30-27(35)32-21-11-8-19(9-12-21)25(28)29)20-10-13-23(22(14-20)26(34)36-2)37-16-18-6-4-3-5-7-18/h3-14,17H,15-16H2,1-2H3,(H3,28,29)(H,31,33)(H2,30,32,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148950
(CHEMBL332753 | N-[1-(3-Bromo-4-morpholin-4-yl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(N2CCOCC2)c(Br)c1 Show InChI InChI=1S/C22H27BrN6O3/c1-14(16-4-7-19(18(23)12-16)29-8-10-32-11-9-29)27-20(30)13-26-22(31)28-17-5-2-15(3-6-17)21(24)25/h2-7,12,14H,8-11,13H2,1H3,(H3,24,25)(H,27,30)(H2,26,28,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 650 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50126582
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-(3,4-dichl...)Show SMILES NC(=N)c1ccc(NC(=O)NCC(=O)NCc2ccc(Cl)c(Cl)c2)cc1 Show InChI InChI=1S/C17H17Cl2N5O2/c18-13-6-1-10(7-14(13)19)8-22-15(25)9-23-17(26)24-12-4-2-11(3-5-12)16(20)21/h1-7H,8-9H2,(H3,20,21)(H,22,25)(H2,23,24,26) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 970 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148954
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-morp...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(N2CCOCC2)c(c1)C(F)(F)F Show InChI InChI=1S/C23H27F3N6O3/c1-14(16-4-7-19(18(12-16)23(24,25)26)32-8-10-35-11-9-32)30-20(33)13-29-22(34)31-17-5-2-15(3-6-17)21(27)28/h2-7,12,14H,8-11,13H2,1H3,(H3,27,28)(H,30,33)(H2,29,31,34) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148958
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-c...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(OCc2cccc(Cl)c2)cc1 Show InChI InChI=1S/C25H26ClN5O3/c1-16(18-7-11-22(12-8-18)34-15-17-3-2-4-20(26)13-17)30-23(32)14-29-25(33)31-21-9-5-19(6-10-21)24(27)28/h2-13,16H,14-15H2,1H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148945
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-m...)Show SMILES COc1cccc(COc2ccc(cc2)C(C)NC(=O)CNC(=O)Nc2ccc(cc2)C(N)=N)c1 Show InChI InChI=1S/C26H29N5O4/c1-17(19-8-12-22(13-9-19)35-16-18-4-3-5-23(14-18)34-2)30-24(32)15-29-26(33)31-21-10-6-20(7-11-21)25(27)28/h3-14,17H,15-16H2,1-2H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148960
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-nap...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc2ccccc2c1 Show InChI InChI=1S/C22H23N5O2/c1-14(17-7-6-15-4-2-3-5-18(15)12-17)26-20(28)13-25-22(29)27-19-10-8-16(9-11-19)21(23)24/h2-12,14H,13H2,1H3,(H3,23,24)(H,26,28)(H2,25,27,29)/t14-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148955
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-morp...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(cc1)N1CCOCC1 Show InChI InChI=1S/C22H28N6O3/c1-15(16-4-8-19(9-5-16)28-10-12-31-13-11-28)26-20(29)14-25-22(30)27-18-6-2-17(3-7-18)21(23)24/h2-9,15H,10-14H2,1H3,(H3,23,24)(H,26,29)(H2,25,27,30) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148951
(CHEMBL330943 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)c2ccccc2)cc1 Show InChI InChI=1S/C25H26N6O3/c1-16(17-7-11-20(12-8-17)30-24(33)19-5-3-2-4-6-19)29-22(32)15-28-25(34)31-21-13-9-18(10-14-21)23(26)27/h2-14,16H,15H2,1H3,(H3,26,27)(H,29,32)(H,30,33)(H2,28,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148960
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-nap...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc2ccccc2c1 Show InChI InChI=1S/C22H23N5O2/c1-14(17-7-6-15-4-2-3-5-18(15)12-17)26-20(28)13-25-22(29)27-19-10-8-16(9-11-19)21(23)24/h2-12,14H,13H2,1H3,(H3,23,24)(H,26,28)(H2,25,27,29)/t14-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148957
(CHEMBL122765 | N-[1-((S)-4-Bromo-phenyl)-ethyl]-2-...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Br)cc1 Show InChI InChI=1S/C18H20BrN5O2/c1-11(12-2-6-14(19)7-3-12)23-16(25)10-22-18(26)24-15-8-4-13(5-9-15)17(20)21/h2-9,11H,10H2,1H3,(H3,20,21)(H,23,25)(H2,22,24,26)/t11-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor VII
(Homo sapiens (Human)) | BDBM50148962
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((R)-1-nap...)Show SMILES C[C@@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc2ccccc2c1 Show InChI InChI=1S/C22H23N5O2/c1-14(17-7-6-15-4-2-3-5-18(15)12-17)26-20(28)13-25-22(29)27-19-10-8-16(9-11-19)21(23)24/h2-12,14H,13H2,1H3,(H3,23,24)(H,26,28)(H2,25,27,29)/t14-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 7.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of human coagulation factor VIIa |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148959
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Oc2ccccc2)cc1 Show InChI InChI=1S/C24H25N5O3/c1-16(17-9-13-21(14-10-17)32-20-5-3-2-4-6-20)28-22(30)15-27-24(31)29-19-11-7-18(8-12-19)23(25)26/h2-14,16H,15H2,1H3,(H3,25,26)(H,28,30)(H2,27,29,31) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 9.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50148944
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(4-m...)Show SMILES COc1ccc(Oc2ccc(cc2)C(C)NC(=O)CNC(=O)Nc2ccc(cc2)C(N)=N)cc1 Show InChI InChI=1S/C25H27N5O4/c1-16(17-5-9-21(10-6-17)34-22-13-11-20(33-2)12-14-22)29-23(31)15-28-25(32)30-19-7-3-18(4-8-19)24(26)27/h3-14,16H,15H2,1-2H3,(H3,26,27)(H,29,31)(H2,28,30,32) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 9.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of thrombin |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148958
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-c...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(OCc2cccc(Cl)c2)cc1 Show InChI InChI=1S/C25H26ClN5O3/c1-16(18-7-11-22(12-8-18)34-15-17-3-2-4-20(26)13-17)30-23(32)14-29-25(33)31-21-9-5-19(6-10-21)24(27)28/h2-13,16H,14-15H2,1H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148953
(4-(1-{2-[3-(4-Carbamimidoyl-phenyl)-ureido]-acetyl...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(cc1)C(=O)Nc1ccccc1 Show InChI InChI=1S/C25H26N6O3/c1-16(17-7-9-19(10-8-17)24(33)30-20-5-3-2-4-6-20)29-22(32)15-28-25(34)31-21-13-11-18(12-14-21)23(26)27/h2-14,16H,15H2,1H3,(H3,26,27)(H,29,32)(H,30,33)(H2,28,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148961
(2-Benzyloxy-5-(1-{2-[3-(4-carbamimidoyl-phenyl)-ur...)Show SMILES COC(=O)c1cc(ccc1OCc1ccccc1)C(C)NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N Show InChI InChI=1S/C27H29N5O5/c1-17(31-24(33)15-30-27(35)32-21-11-8-19(9-12-21)25(28)29)20-10-13-23(22(14-20)26(34)36-2)37-16-18-6-4-3-5-7-18/h3-14,17H,15-16H2,1-2H3,(H3,28,29)(H,31,33)(H2,30,32,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50126585
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-((S)-1-phe...)Show SMILES C[C@H](NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccccc1 Show InChI InChI=1S/C18H21N5O2/c1-12(13-5-3-2-4-6-13)22-16(24)11-21-18(25)23-15-9-7-14(8-10-15)17(19)20/h2-10,12H,11H2,1H3,(H3,19,20)(H,22,24)(H2,21,23,25)/t12-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148945
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-{1-[4-(3-m...)Show SMILES COc1cccc(COc2ccc(cc2)C(C)NC(=O)CNC(=O)Nc2ccc(cc2)C(N)=N)c1 Show InChI InChI=1S/C26H29N5O4/c1-17(19-8-12-22(13-9-19)35-16-18-4-3-5-23(14-18)34-2)30-24(32)15-29-26(33)31-21-10-6-20(7-11-21)25(27)28/h3-14,17H,15-16H2,1-2H3,(H3,27,28)(H,30,32)(H2,29,31,33) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148959
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(Oc2ccccc2)cc1 Show InChI InChI=1S/C24H25N5O3/c1-16(17-9-13-21(14-10-17)32-20-5-3-2-4-6-20)28-22(30)15-27-24(31)29-19-11-7-18(8-12-19)23(25)26/h2-14,16H,15H2,1H3,(H3,25,26)(H,28,30)(H2,27,29,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148946
(4-(1-{2-[3-(4-Carbamimidoyl-phenyl)-ureido]-acetyl...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(cc1)C(=O)Nc1cccc(Oc2ccccc2)c1 Show InChI InChI=1S/C31H30N6O4/c1-20(35-28(38)19-34-31(40)37-24-16-14-22(15-17-24)29(32)33)21-10-12-23(13-11-21)30(39)36-25-6-5-9-27(18-25)41-26-7-3-2-4-8-26/h2-18,20H,19H2,1H3,(H3,32,33)(H,35,38)(H,36,39)(H2,34,37,40) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148950
(CHEMBL332753 | N-[1-(3-Bromo-4-morpholin-4-yl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(N2CCOCC2)c(Br)c1 Show InChI InChI=1S/C22H27BrN6O3/c1-14(16-4-7-19(18(23)12-16)29-8-10-32-11-9-29)27-20(30)13-26-22(31)28-17-5-2-15(3-6-17)21(24)25/h2-7,12,14H,8-11,13H2,1H3,(H3,24,25)(H,27,30)(H2,26,28,31) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148954
(2-[3-(4-Carbamimidoyl-phenyl)-ureido]-N-[1-(4-morp...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(N2CCOCC2)c(c1)C(F)(F)F Show InChI InChI=1S/C23H27F3N6O3/c1-14(16-4-7-19(18(12-16)23(24,25)26)32-8-10-35-11-9-32)30-20(33)13-29-22(34)31-17-5-2-15(3-6-17)21(27)28/h2-7,12,14H,8-11,13H2,1H3,(H3,27,28)(H,30,33)(H2,29,31,34) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |
Coagulation factor X
(Homo sapiens (Human)) | BDBM50148949
(CHEMBL339200 | N-[4-(1-{2-[3-(4-Carbamimidoyl-phen...)Show SMILES CC(NC(=O)CNC(=O)Nc1ccc(cc1)C(N)=N)c1ccc(NC(=O)c2cccc(C)c2)cc1 Show InChI InChI=1S/C26H28N6O3/c1-16-4-3-5-20(14-16)25(34)31-21-10-6-18(7-11-21)17(2)30-23(33)15-29-26(35)32-22-12-8-19(9-13-22)24(27)28/h3-14,17H,15H2,1-2H3,(H3,27,28)(H,30,33)(H,31,34)(H2,29,32,35) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Aventis Pharma Deutschland GmbH
Curated by ChEMBL
| Assay Description In vitro inhibition of coagulation factor X |
Bioorg Med Chem Lett 14: 3715-20 (2004)
Article DOI: 10.1016/j.bmcl.2004.05.006 BindingDB Entry DOI: 10.7270/Q2PG1R6T |
More data for this Ligand-Target Pair | |